Section divider

Since 1993, improving health, saving lives and responding to disease outbreaks.

  • At Jhpiego-supported health care facilities, more than 426,000 deliveries were attended by a skilled birth attendant and more than 9 million women started using a modern family planning (FP) method for the first time.
  • The Health Service Delivery (HSD) project assisted Guinea’s Ministry of Health to define an integrated package of essential services and helped increase the number of facilities offering the full package from 79 in 2017 to 261 in 2022 (94% of project target).
  • To date, HSD has trained 117 providers, 143 community educators 30 paralegals and 50 protection officers in gender-based violence (GBV) services, including clinical management, referral and reporting, educational messages for prevention and awareness building of community resources. In the three years that HSD has supported GBV activities, more than 1600 cases have been managed at 56 project-supported facilities for this intervention.
  • Jhpiego supported COVID-19 vaccination in two regions, Boke and Kindia. Through support to organize and mobilize teams of vaccinators and ensure waste management, more than 2.3 million doses have been administered, with 1.04 million fully vaccinated with two doses or a single dose product. As a result, second dose coverage in these regions is 55% and 46%, respectively, of target—well exceeding the national average of 25%.

Our Work in Guinea

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is working closely with the Access Collaborative to strengthen health systems to accelerate introduction and scale-up of DMPA-SC in select West African countries, including Guinea.

With funds from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Guinean Ministry of Health is supporting Jhpiego to strengthen and decentralize the national response to sexually transmitted infections, including HIV, with the goal of universal access to services. The goal of this program is to reduce new HIV infections and reduce the mortality and morbidity among people living with HIV. Jhpiego is leading the prevention of mother-to-child transmission of HIV (PMTCT) component of the program, focusing initially on consolidating gains and improving performance in PMTCT service provision followed by extension to additional sites.


This multi-country project is catalyzing the introduction and adoption pathways for quality-assured drugs to treat postpartum hemorrhage (i.e., heat-stable carbetocin, tranexamic acid and misoprostol) through engagement and coordination with country governments and key stakeholders. The project aims to reduce maternal mortality and morbidity by making sure the right drug is in the right place at the right time for the right indication. Funded by Unitaid, AMPLI-PPHI is led by Jhpiego and supported by consortium partners PATH and the International Federation of Gynaecology and Obstetrics (FIGO). In addition to operating in four target countries (the Democratic Republic of Congo, Guinea, Kenya and India), an additional 13 other influence countries are benefitting from country and learning exchanges as well as from the sharing of project learning, resources and tools. For more information, please visit the project website.